2022-RA-898-ESGO Overexpression of TMED9 is important prognostic biomarker for epithelial ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

2022-RA-898-ESGO Overexpression of TMED9 is important prognostic biomarker for epithelial ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

	Abstract	Full	Pdf
Oct 2022	13	0	1
Nov 2022	28	0	3
Dec 2022	36	0	7
Jan 2023	30	0	4
Feb 2023	11	0	1
Mar 2023	16	0	1
Apr 2023	10	0	3
May 2023	8	0	0
Jun 2023	16	0	2
Jul 2023	18	0	6
Aug 2023	7	0	4
Sep 2023	3	0	2
Oct 2023	6	0	1
Nov 2023	12	0	3
Dec 2023	17	0	2
Jan 2024	8	0	1
Feb 2024	9	0	2
Mar 2024	10	0	4
Apr 2024	15	0	8
Total	273	0	55